Guided Therapeutics (GTHP) Share-based Compensation (2011 - 2025)
Guided Therapeutics' (GTHP) quarterly Share-based Compensation came in at $25000.0 in Q4 2025, up 292.31% year-on-year from $6372.5 in Q4 2024, and up 65.37% quarter-over-quarter from $15118.0 in Q3 2025.
Guided Therapeutics (GTHP) Share-based Compensation (2011 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Share-based Compensation across 15 years of filings, most recently posting $25000.0 for Q4 2025.
- Share-based Compensation for Q4 2025 came in at $25000.0, up 292.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $55518.0 (up 183.6% YoY), and the FY2025 annual result was $377000.0, up 214.17% from the prior year.
- Share-based Compensation came in at $25000.0 for Q4 2025 at Guided Therapeutics, up from $15118.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.1 million in Q2 2023 to a low of -$821353.0 in Q4 2022.
- The 5-year median for Share-based Compensation is $21091.5 (2023), against an average of $62996.2.
- Across the five-year window, Share-based Compensation sank 1742.71% in 2022 and soared 2443.18% in 2023, its largest moves.
- Guided Therapeutics' Share-based Compensation stood at $50000.0 in 2021, then tumbled by 1742.71% to -$821353.0 in 2022, then surged by 93.43% to -$54000.0 in 2023, then soared by 75.93% to -$13000.0 in 2024, then surged by 292.31% to $25000.0 in 2025.
- The last three Share-based Compensation figures came in at $25000.0 (Q4 2025), $15118.0 (Q3 2025), and $15381.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 15,118.00 |
| Sep 30, 2025 | 15,118.00 |
| Jun 30, 2025 | 15,381.00 |
| Jun 30, 2025 | 15,381.00 |
| Mar 31, 2025 | 19.00 |
| Mar 31, 2025 | 19.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 16,145.00 |
| Sep 30, 2024 | 16,145.00 |
| Jun 30, 2024 | 16,401.00 |
| Jun 30, 2024 | 16,401.00 |
| Mar 31, 2024 | 30.00 |
| Mar 31, 2024 | 30.00 |
| Dec 31, 2023 | -54,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Sep 30, 2023 | 17,183.00 |
| Sep 30, 2023 | 17,183.00 |